|
Volumn 8, Issue 4, 2001, Pages 252-261
|
Double-blind, placebo-controlled, randomised cross-over clinical trial of NIPRISAN® in patients with Sickle Cell Disorder
a a b a a c d a a a a a a a a a e |
Author keywords
Acute toxicity; Crisis; NIPRISAN ; Severe pains; Sickle Cell Disorder
|
Indexed keywords
NIPRISAN;
UNCLASSIFIED DRUG;
ACUTE TOXICITY;
ADULT;
ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CROSSOVER PROCEDURE;
DOUBLE BLIND PROCEDURE;
DRUG EFFICACY;
DRUG SAFETY;
FEMALE;
HEADACHE;
HUMAN;
KIDNEY FUNCTION;
MAJOR CLINICAL STUDY;
MALE;
MEDICINAL PLANT;
PAIN;
PHYTOCHEMISTRY;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
RASH;
SICKLE CELL ANEMIA;
UREA NITROGEN BLOOD LEVEL;
|
EID: 0034887027
PISSN: 09447113
EISSN: None
Source Type: Journal
DOI: 10.1078/0944-7113-00040 Document Type: Article |
Times cited : (81)
|
References (12)
|